Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD)
Clinical trial NCT03393806 · TERMINATED
Trial details
- NCT number
- NCT03393806
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-18
- Primary completion
- 2019-10-09
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.